Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 316 AL 330

HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders

Li Y, Izhar T, Kanekiyo T.

Mol Neurobiol. 2025 Aug;62(8):9573-9585. doi: 10.1007/s12035-025-04866-w. Epub 2025 Mar 24.

Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer's disease: a comprehensive review of the characteristics and therapeutic strategies

Nam Y, Shin SJ, Kumar V, Won J, Kim S, Moon M.

Transl Neurodegener. 2025 Mar 26;14(1):15. doi: 10.1186/s40035-025-00479-4.

Cholesterol´s role in membrane organization and nicotinic acetylcholine receptor function: Implications for aging and Alzheimer's disease

Peñalva DA, Munafó JP, Antollini SS.

Chem Phys Lipids. 2025 Jul;269:105484. doi: 10.1016/j.chemphyslip.2025.105484. Epub 2025 Mar 25.

Targeting amyloidogenic proteins through cyclic peptides - A medicinal chemistry perspective

Zargaham MK, Ibrahim A, Ahmed M, Babar MM, Rajadas J.

Bioorg Med Chem. 2025 Jun 1;123:118165. doi: 10.1016/j.bmc.2025.118165. Epub 2025 Mar 19.

A review: From old drugs to new solutions: The role of repositioning in alzheimer's disease treatment

Shah FA, Qadir H, Khan JZ, Faheem M.

Neuroscience. 2025 Jun 7;576:167-181. doi: 10.1016/j.neuroscience.2025.03.064. Epub 2025 Mar 29.

Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition

Almohmadi NH, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Fakhry MM, Alexiou A, Papadakis M, Batiha GE.

Chem Biodivers. 2025 Aug;22(8):e202403401. doi: 10.1002/cbdv.202403401. Epub 2025 Jun 3.

Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms

Abbas K, Mustafa M, Alam M, Habib S, Ahmad W, Adnan M, Hassan MI, Usmani N.

Neurogenetics. 2025 Apr 1;26(1):39. doi: 10.1007/s10048-025-00821-y.

Implication of Central β(2) Adrenergic Receptor for the Development of Novel Drugs Against Alzheimer's Disease

Wang A, Since M, Dallemagne P, Rochais C.

Arch Pharm (Weinheim). 2025 Apr;358(4):e2400750. doi: 10.1002/ardp.202400750.

Exploring the nexus: Sleep disorders, circadian dysregulation, and Alzheimer's disease

Khandayataray P, Murthy MK.

Neuroscience. 2025 May 14;574:21-41. doi: 10.1016/j.neuroscience.2025.03.066. Epub 2025 Apr 4.

The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model

Titisari N, Ahmad H, Samsulrizal N, Fauzi A, Abdul Razak IS.

Open Vet J. 2025 Feb;15(2):594-600. doi: 10.5455/OVJ.2025.v15.i2.8. Epub 2025 Feb 28.

Harnessing marine resources for Alzheimer's therapy: A review integrating bioactivity and molecular docking

Khalid H, Mohamed H, Eltoukhy A, Saeed MT, Song Y.

Eur J Pharmacol. 2025 Jun 15;997:177611. doi: 10.1016/j.ejphar.2025.177611. Epub 2025 Apr 9.

Exploring Retinal Neurodegeneration in Alzheimer's Disease: A Molecular and Cellular Perspective

Dhapola R, Sharma P, Kumari S, Vellingiri B, Medhi B, HariKrishnaReddy D.

Neurotox Res. 2025 Apr 12;43(2):22. doi: 10.1007/s12640-025-00744-4.

Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease

Bianchini MC, Franscescon F, Soares AA, Ansolin V, Pretto KP, da Cunha MLV, de Resende E Silva DT.

Curr Neuropharmacol. 2025;23(11):1367-1379. doi: 10.2174/011570159X355614250130100132.

Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease

Ozturk B, Demir H, Gunay MS, Akdag Y, Sahin S, Gulsun T.

Curr Neuropharmacol. 2025;23(14):1985-2003. doi: 10.2174/011570159X370790250317045223.

Past, present, and future of serotonin-targeting therapeutics for Alzheimer's disease: Perspectives from DNA methylation

Liu Y, Aquili L, Wong KH, Lu Z, Lim LW.

Ageing Res Rev. 2025 Jun;108:102755. doi: 10.1016/j.arr.2025.102755. Epub 2025 Apr 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias